# ZYMEWORKS INC. (ZYME) FY2026 Q2 Balance Sheet

- Company: ZYMEWORKS INC. (ZYME)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001937653-26-000047
- Page: https://plicit.ai/financials/zyme/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/zyme-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 396,964,000 US dollars
- **Current assets**: 298,388,000 US dollars
- **Non-current assets**: 98,576,000 US dollars
- **Liabilities**: 316,595,000 US dollars
- **Current liabilities**: 47,243,000 US dollars
- **Non-current liabilities**: 269,352,000 US dollars
- **Equity**: 80,369,000 US dollars
- **Cash and cash equivalents**: 179,413,000 US dollars
- **Short-term marketable securities**: 91,286,000 US dollars
- **Prepaid expenses and other current assets**: 21,759,000 US dollars
- **Accounts receivable**: 5,930,000 US dollars
- **Long-term marketable securities**: 51,777,000 US dollars
- **Property and equipment, net**: 13,955,000 US dollars
- **Operating lease right-of-use assets**: 13,195,000 US dollars
- **Goodwill**: 12,016,000 US dollars
- **Deferred tax asset**: 4,354,000 US dollars
- **Long-term prepaids and other assets**: 2,281,000 US dollars
- **Intangible assets, net**: 998,000 US dollars
- **Accounts payable and accrued liabilities**: 27,458,000 US dollars
- **Deferred revenue**: 16,436,000 US dollars
- **Current portion of operating lease liability**: 3,304,000 US dollars
- **Income tax payable**: 45,000 US dollars
- **Liability related to sale of future royalties**: 252,631,000 US dollars
- **Long-term portion of operating lease liability**: 12,703,000 US dollars
- **Deferred tax liability**: 3,740,000 US dollars
- **Other long-term liabilities**: 278,000 US dollars
- **Deferred revenue**: 0 US dollars
- **Common stock, $0.00001 par value; 900,000,000 authorized shares at June 30, 2026 and December 31, 2025, respectively; 71,412,072 and 74,638,413 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively**: 1,133,959,000 US dollars
- **Additional paid-in capital**: 116,450,000 US dollars
- **Exchangeable shares, no par value, 550,000 and 553,184 issued and outstanding shares at June 30, 2026 and December 31, 2025, respectively**: 7,892,000 US dollars
- **Preferred shares, $0.00001 par value; 100,000,000 authorized shares of preferred stock, out of which, one share of preferred stock is a share of Special Voting Preferred Stock and outstanding as of June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 1,171,238,000 US dollars
- **Accumulated other comprehensive loss**: negative 6,694,000 US dollars
- **Gross equity (calculated)**: 1,258,301,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.